RCC1 and melanoma: Here, we report that treatment of melanoma cells with GTPs reduces the melanoma cell viability and this effect of GTPs is mediated through, (i) inhibition of the levels of class I HADC proteins, (ii) inhibition of HDAC activity while enhancing HAT activity, (iii) DNA damage and (iv) suppression of cell cycle regulatory proteins of G1 phase.